Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADC Agree

Pre-Market Trading 12-23 06:53:16 EST

70.17

+0.73

+1.05%

盘前70.73

+0.56+0.80%

05:23 EST

High71.13	Low68.97	Vol4.30M
Open70.00	D1 Closing69.44	Amplitude3.11%
Mkt Cap7.65B	Tradable Cap7.51B	Total Shares109.00M
T/O301.86M	T/O Rate4.02%	Tradable Shares107.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"Agree","latestPrice":70.17,"timestamp":1734728400000,"preClose":69.44,"halted":0,"volume":4301383,"hourTrading":{"tag":"盘前","latestPrice":70.73,"preClose":70.17,"latestTime":"05:23 EST","volume":1,"amount":70.73,"timestamp":1734949424553},"delay":0,"floatShares":107000000,"shares":109000000,"eps":1.809026,"marketStatus":"Pre-Market Trading","change":0.73,"latestTime":"12-23 06:53:16 EST","open":70,"high":71.13,"low":68.97,"amount":301859376.383772,"amplitude":0.031106,"askPrice":83.31,"askSize":100,"bidPrice":59.97,"bidSize":100,"shortable":3,"etf":0,"ttmEps":1.809026,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1734964200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":70.17,"dividendRate":0.042497,"preHourTrading":{"tag":"盘前","latestPrice":70.73,"preClose":70.17,"latestTime":"05:23 EST","volume":1,"amount":70.73,"timestamp":1734949424553},"postHourTrading":{"tag":"盘后","latestPrice":70.17,"preClose":70.17,"latestTime":"18:27 EST","volume":1028497,"amount":72169572.419,"timestamp":1734737273693},"volumeRatio":4.477722891044755,"impliedVol":0.2357,"impliedVolPercentile":0.672},"requestUrl":"/m/hq/s/ADC/wiki","defaultTab":"wiki","newsList":[{"id":"2493276385","title":"News Corp, Telstra Agree to Sell Foxtel to DAZN in $2.1 Billion Deal -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2493276385","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493276385?lang=en_us&edition=fundamental","pubTime":"2024-12-23 08:10","pubTimestamp":1734912600,"startTime":"0","endTime":"0","summary":"News Corp and Australian telecom company Telstra have agreed to sell their jointly owned pay television company, Foxtel, to sports streaming service DAZN Group in a deal that values Foxtel at around US$2.1 billion.News Corp said Monday that the sale of Foxtel, in which it holds a 65% stake, will allow the company to sharpen its focus on key growth areas--digital real estate services, book publishing and Dow Jones, the publisher of this newswire and The Wall Street Journal.News Corp Chief Executive Robert Thomson said in August that News Corp was evaluating its options for Foxtel after receiving interest from a potential suitor.The deal would allow News Corp to benefit from the repayment of shareholder loans and an improved credit profile, Thomson said Monday.Under the agreement, which values Foxtel at 3.4 billion Australian dollars, equivalent to US$2.1 billion, A$578 million of shareholder loans owed to News Corp will be repaid in full, the company said. Following the transaction, New","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7038","TLS.AU","ADC","BK4585","NWS","BK7511","NWSA","BK7042","LU1169590202.USD","NWS.AU","BK4111","BK4588","BK4231","BK4080","LU1169589451.USD"],"gpt_icon":0},{"id":"2493228663","title":"Why Pfizer Inc. (PFE) Is One of the Best Stocks to Buy and Hold for 3 Years?","url":"https://stock-news.laohu8.com/highlight/detail?id=2493228663","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493228663?lang=en_us&edition=fundamental","pubTime":"2024-12-23 00:13","pubTimestamp":1734883984,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Best Stocks to Buy and Hold For 3 Years. In this article, we are going to take a look at where Pfizer Inc.  stands against the other best stocks to buy and hold for 3 years.What to Expect From the Stock Market in 2025?To compile the list of 10 best stocks to buy and hold for 3 years, we applied a consensus approach. We sifted through recent articles to get an aggregated list of the best stocks to buy and hold for 3 years. Next, we ranked t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/nfjb.LNlllEDA_JnVIKIaA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/nfjb.LNlllEDA_JnVIKIaA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-pfizer-inc-pfe-one-161304556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1023059063.AUD","LU1883839398.USD","BK4550","BK4231","LU0225284248.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","ADC","SG9999013999.USD","LU0321505868.SGD","LU1066051498.USD","LU0306806265.USD","BK4007","BK4599","BK4581","BK4080","LU0225771236.USD","LU0985481810.HKD","BK4534","LU0122379950.USD","LU0289739699.SGD","SG9999003800.SGD","LU0456855351.SGD","BK4592","BK4588","SG9999002232.USD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","LU1057294990.SGD","LU0234572021.USD","SG9999001176.SGD","SG9999002224.SGD","LU0306807586.USD","PFE","BK4585","SGXZ57979304.SGD","LU1066053197.SGD","SG9999001176.USD","LU0170899867.USD","LU1894683348.USD","IE000M9KFDE8.USD","LU0868494617.USD","BK4568","LU0321505439.SGD","IE00BLSP4452.SGD","IE0002270589.USD","BK4533","LU0058720904.USD","SG9999011175.SGD"],"gpt_icon":1},{"id":"2493210789","title":"3 Reasons to Buy Agree Realty Stock Like There's No Tomorrow","url":"https://stock-news.laohu8.com/highlight/detail?id=2493210789","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493210789?lang=en_us&edition=fundamental","pubTime":"2024-12-22 17:55","pubTimestamp":1734861300,"startTime":"0","endTime":"0","summary":"This relatively unknown $7 billion name deserves a closer look from income-minded investors.","market":"fut","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F801599%2Fwoman-thinking-brainstorming-ideas.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F801599%2Fwoman-thinking-brainstorming-ideas.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com/investing/2024/12/22/3-reasons-to-buy-agree-realty-stock-like-theres-no/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4231","BK4080","ADC"],"gpt_icon":0},{"id":"2493387092","title":"Should You Buy This Millionaire-Maker Stock Instead of Agree Realty?","url":"https://stock-news.laohu8.com/highlight/detail?id=2493387092","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493387092?lang=en_us&edition=fundamental","pubTime":"2024-12-21 15:48","pubTimestamp":1734767280,"startTime":"0","endTime":"0","summary":"Agree Realty has been growing quickly over the past decade.The stock of the net lease REIT has risen over 15% in 2024.Realty Income's stock price has fallen nearly 5% and comes with a higher yield and a longer dividend growth streak.","market":"us","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F801326%2F22_04_25-a-hand-drawing-puzzle-pieces-with-the-words-price-and-value-on-them-_gettyimages-477457721.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F801326%2F22_04_25-a-hand-drawing-puzzle-pieces-with-the-words-price-and-value-on-them-_gettyimages-477457721.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com/investing/2024/12/21/should-you-buy-this-millionaire-maker-stock-instea/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE00B894F039.SGD","LU0950375773.USD","TJX","REIT","LU2237443978.SGD","LU0823417737.USD","LU0823417653.USD","IE00B19Z9Z06.USD","LU1989772840.SGD","LU1989772923.USD","LU2237443382.USD","IE0004445239.USD","IE00B1BXHZ80.USD","LU2506951875.HKD","IE00B19Z9P08.USD","LU2506952097.USD","LU2237443465.HKD","IE00BZ9MQY76.HKD","BK4080","ADC","BK4231","LU2092937221.SGD","LU2041044095.USD","LU2506952170.USD","BK4094","LU2237443549.SGD","LU0094547139.USD","BK4592","GRO","LU2237443622.USD","BK4585","LU2133065610.SGD","BK4588","LU2237443895.HKD","LU2506951958.HKD"],"gpt_icon":0},{"id":"2493472185","title":"Italy’s Open Fiber Investors Agree on €3 Billion Financing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2493472185","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493472185?lang=en_us&edition=fundamental","pubTime":"2024-12-21 03:32","pubTimestamp":1734723136,"startTime":"0","endTime":"0","summary":"Open Fiber SpA’s shareholders and banks agreed to secure about €3 billion ($3.1 billion) of financing, including €2 billion of new debt and equity in a move aimed at shoring up financial strains at the state-backed fiber carrier.","market":"sg","thumbnail":"https://www.bnnbloomberg.ca/resizer/v2/ASFKRSDFXCOIL4A4MU6CRV42I4.jpg?smart=true&auth=ed46778ab1f44f2ceab2269a0d470a107d83cd0a31c4148f54084c722f60bd2a&width=500&height=333","type":0,"news_type":0,"thumbnails":["https://www.bnnbloomberg.ca/resizer/v2/ASFKRSDFXCOIL4A4MU6CRV42I4.jpg?smart=true&auth=ed46778ab1f44f2ceab2269a0d470a107d83cd0a31c4148f54084c722f60bd2a&width=500&height=333"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.bnnbloomberg.ca/business/company-news/2024/12/20/italys-open-fiber-investors-agree-on-3-billion-financing-deal/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bnn_bloomberg_highlight","symbols":["ISBC","BK4231","BK4080","BK4211","ADC"],"gpt_icon":0},{"id":"2492446036","title":"BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points","url":"https://stock-news.laohu8.com/highlight/detail?id=2492446036","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492446036?lang=en_us&edition=fundamental","pubTime":"2024-12-20 22:00","pubTimestamp":1734703200,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Dec.  20, 2024  (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company (“BioAtla” or the “Company”) focused on the development of Conditionally Acti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/20/3000632/0/en/BioAtla-Inc-Announces-Registered-Direct-Offering-to-Advance-Two-Mid-Stage-Clinical-Programs-to-Key-Inflection-Points.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPXX","SSI","BK4122","CAB","BK4080","BK4139","ADC","BK4231","PCOM","BCAB"],"gpt_icon":0},{"id":"2492491449","title":"Swiss Agree EU Deal, Rebuilding Ties After 2021 Breakdown","url":"https://stock-news.laohu8.com/highlight/detail?id=2492491449","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492491449?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:36","pubTimestamp":1734701774,"startTime":"0","endTime":"0","summary":"Switzerland and the European Union agreed on a deal to ensure the country’s access to the bloc’s single market, hitting an unofficial end-of-year deadline after lengthy and intense talks.","market":"fut","thumbnail":"https://static.themebuilder.aws.arc.pub/bellmediainc/1717607291216.jpg","type":0,"news_type":0,"thumbnails":["https://static.themebuilder.aws.arc.pub/bellmediainc/1717607291216.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.bnnbloomberg.ca/investing/2024/12/20/swiss-agree-eu-deal-rebuilding-ties-after-2021-breakdown/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bnn_bloomberg_highlight","symbols":["BK4156","BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2492417633","title":"Aadi Bioscience Obtains Rights to ADC Portfolio, Signs $200 Million Deals; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2492417633","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492417633?lang=en_us&edition=fundamental","pubTime":"2024-12-20 20:34","pubTimestamp":1734698088,"startTime":"0","endTime":"0","summary":"Aadi Bioscience (AADI) shares were up more than 24% premarket Friday after the company said it signed an exclusive license agreement for a portfolio of preclinical antibody-drug conjugates, or ADCs, a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AADI","BK4139","BK4231","BK4080","ADC"],"gpt_icon":0},{"id":"2492173524","title":"Is Pfizer (PFE) a Cheap NYSE Stock to Invest in Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2492173524","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492173524?lang=en_us&edition=fundamental","pubTime":"2024-12-20 20:19","pubTimestamp":1734697161,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Cheap NYSE Stocks To Invest In Now. In this article, we are going to take a look at where Pfizer Inc.  stands against other cheap NYSE stocks to invest in now.The stock market appears poised for another year of impressive returns, likely extending into 2025. However, concerns about high valuations persist. To gain insight into this, Aswath Damodaran, professor of finance at NYU Stern School of Business, recently joined CNBC’s ‘Closing Bell’ on December 14. Damodaran recognized that it’s tough to keep up after two years of returns over 25%. He mentioned that if the market stays stable until the end of the year, it would be similar to the high points seen in the 1950s and mid-1970s. However, he was doubtful about being able to keep this strong performance going, as it’s challenging to continue rising after such big gains.Markets are constantly evolving, influenced by various factors such as economic growth, interest rates, and geopolitical events. Damod","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/nfjb.LNlllEDA_JnVIKIaA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/nfjb.LNlllEDA_JnVIKIaA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-pfe-cheap-nyse-stock-121921079.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0868494617.USD","LU1057294990.SGD","SGXZ57979304.SGD","LU0225284248.USD","LU0225771236.USD","LU0321505439.SGD","BK4585","LU0058720904.USD","BK4592","NYSE","SG9999002224.SGD","LU0289739699.SGD","LU1066051498.USD","LU1883839398.USD","IE000M9KFDE8.USD","LU1894683348.USD","SG9999001176.USD","IE00BLSP4239.USD","BK4550","LU0306807586.USD","LU0321505868.SGD","BK4080","LU1023059063.AUD","BK4534","IE00BLSP4452.SGD","PFE","SG9999013999.USD","SG9999003800.SGD","SG9999002232.USD","LU0122379950.USD","SG9999001176.SGD","LU0234572021.USD","LU0985481810.HKD","BK4533","BK4568","BK4599","BK4231","LU0456855351.SGD","LU0306806265.USD","LU1066053197.SGD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4007","SG9999011175.SGD","ADC","BK4588","LU0170899867.USD","IE00B19Z3581.USD","LU1894683264.USD"],"gpt_icon":1},{"id":"2492493694","title":"Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2492493694","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492493694?lang=en_us&edition=fundamental","pubTime":"2024-12-20 14:00","pubTimestamp":1734674400,"startTime":"0","endTime":"0","summary":"Innate Pharma SA   today announced that its management will present and host 1x1 meetings at the 43rd Annual J.P. Morgan Healthcare Conference being held on January 13-16, 2025 in San Francisco, CA.Jonathan Dickinson, Chief Executive Officer of Innate Pharma, will represent the Company in a session scheduled Tuesday, January 14, 2025 from 11:15 - 11:55 am PST.Other Executive Board members participating in the event will be:. A live video webcast of the presentation will be accessible under the \"Events\" tab on the Investors section of the Company’s website at www.innate-pharma.com and will be available for replay following the event.This press release contains certain forward-looking statements, including those within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. The use of certain words, including \"anticipate,\" \"believe,\" \"can,\" \"could,\" \"estimate,\" \"expect,\" \"may,\" \"might,\" \"potential,\" \"expect\" \"should,\" \"will,\" or the nega","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xscUo4qnoO9SNvb3DDE4AA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/63390f0d711d97e48569a217f06c9310","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xscUo4qnoO9SNvb3DDE4AA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/63390f0d711d97e48569a217f06c9310"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innate-pharma-participate-43rd-annual-060000383.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0098860793.USD","LU2111349929.HKD","LU0795875086.SGD","BK4127","HCSG","LU0971096721.USD","LU1732799900.SGD","LU2028103732.USD","BK4080","BK4516","BK4139","BK4581","ADC","LU2271345857.HKD","IPHA","LU0225283273.USD","BK4504","LU0006306889.USD","LU2357305700.SGD","BK4588","LU0320765646.SGD","LU1720051017.SGD","LU1989772840.SGD","LU0106261372.USD","LU0795875169.SGD","LU1720051108.HKD","LU2089283258.USD","LU1074936037.SGD","LU1668664300.SGD","LU0158827781.USD","LU1732800096.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU2089284900.SGD","LU0314104364.USD","LU1162221912.USD","BK4137","LU0912757837.SGD","BK4585","LU0106831901.USD","LU2023251221.USD","LU1548497426.USD","LU0158827948.USD","LU2347655156.SGD","LU1363072403.SGD","LU0267386448.USD","BK4231","IPHYF","LU1989772923.USD","BK4534"],"gpt_icon":0},{"id":"2492436700","title":"Aadi Bioscience signs license agreement for ADC portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2492436700","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492436700?lang=en_us&edition=fundamental","pubTime":"2024-12-20 07:40","pubTimestamp":1734651627,"startTime":"0","endTime":"0","summary":"Aadi Bioscience (AADI) has entered into an exclusive license agreement for development and global commercialization of a three-asset portfolio of p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aadi-bioscience-signs-license-agreement-for-adc-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aadi-bioscience-signs-license-agreement-for-adc-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AADI","BK4139","BK4231","BK4080","ADC"],"gpt_icon":0},{"id":"2492155436","title":"Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2492155436","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492155436?lang=en_us&edition=fundamental","pubTime":"2024-12-20 07:30","pubTimestamp":1734651000,"startTime":"0","endTime":"0","summary":"Aadi Enters into Exclusive License for Three-Asset ADC Portfolio Developed through a Collaboration between WuXi Biologics and HANGZHOU DAC. Aadi Enters Agreement to Sell FYARRO and Associated Infrastructure to KAKEN Pharmaceutical for $100M; Announces PIPE Financing of $100M. Cumulative Capital Expected to Fund Operations into Late 2028, Including Anticipated ClinicalData for the ADC Portfolio. Co-Founder and Former CEO of ProfoundBio, Baiteng Zhao, Appointed to Aadi Board of Directors. Aadi to Hold Webcast and Conference Call on December 20 at 8:00 AM EST. Per the terms of the license agreement, Aadi is granted exclusive rights to certain patents and know-how pertaining to three preclinical ADC programs leveraging HANGZHOU DAC's CPT113 linker payload technology targeting each of Protein Tyrosine Kinase 7 , Mucin-16  and Seizure Related 6 Homolog . Aadi will pay aggregate upfront payments of $44 million for in-licensing such ADC programs. Additionally, Aadi is obligated to pay cumulati","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7D7kp0ze9dGOe7gdgJQfdQ--~B/aD0yNjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b444accc188c132aa532ecd9d01adab6","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7D7kp0ze9dGOe7gdgJQfdQ--~B/aD0yNjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b444accc188c132aa532ecd9d01adab6"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/aadi-bioscience-transforms-licensing-novel-233000253.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aadi-bioscience-transforms-licensing-novel-233000253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","WRD","ADC","BK4231","PHH","BK4139","AADI"],"gpt_icon":0},{"id":"2492248178","title":"Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201","url":"https://stock-news.laohu8.com/highlight/detail?id=2492248178","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492248178?lang=en_us&edition=fundamental","pubTime":"2024-12-20 05:08","pubTimestamp":1734642480,"startTime":"0","endTime":"0","summary":"- The Company will focus resources on advancing its lead asset, PYX-201 - PYX-201 is a novel first-in-concept antibody-drug conjugate (ADC) where significant RECIST responses were seen in head and nec","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/19/3000256/0/en/Pyxis-Oncology-Announces-Portfolio-Prioritization-Focusing-Resources-on-its-Lead-Clinical-Program-PYX-201.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS","BK4231","IO","BK4139","BK4080","ADC","BK4563","BK4179"],"gpt_icon":0},{"id":"2492165382","title":"Woodside, Chevron Agree to Asset Swap","url":"https://stock-news.laohu8.com/highlight/detail?id=2492165382","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492165382?lang=en_us&edition=fundamental","pubTime":"2024-12-19 06:57","pubTimestamp":1734562620,"startTime":"0","endTime":"0","summary":"Australia's Woodside Energy said Thursday it has agreed to an asset swap with U.S. oil company Chevron that will simplify its business and support investor returns.As part of the deal, Woodside will sell Chevron its 13% non-operated interest in the Wheatstone Project and its 65% operated interest in the Julimar-Brunello Project.Woodside will acquire Chevron's nearly 17% interests in the NWS Project and the NWS Oil Project, and its 20% interest in the Angel CCS Project.Chevron will also make a cash payment to Woodside of up to $400 million, Woodside said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456854461.SGD","LU0098860793.USD","BK4592","LU2133065610.SGD","LU0256863811.USD","LU0368265418.SGD","LU0208291251.USD","WDS.AU","BK7142","BK4585","LU0320765646.SGD","LU0788109394.HKD","LU0070302665.USD","LU1074936037.SGD","LU2237438978.USD","LU0234572021.USD","LU0300736492.USD","LU0942090050.USD","LU0868494708.USD","LU0278409577.USD","LU0300736062.USD","LU1929549753.HKD","LU0868494617.USD","BK4534","BK4588","BK4570","BK4201","IE00B2Q91V27.USD","LU0122376428.USD","LU0640476718.USD","LU1066053197.SGD","BK4566","BK4080","BK4231","BK4559","LU1162221912.USD","BK4213","LU1066051498.USD","LU1496350502.SGD","LU1280957306.USD","LU0266512127.USD","BK4550","WDS","CVX","BK4581","IE00BGHQF524.EUR","LU1496350171.SGD","LU0320765489.SGD","ADC","IE00B3CCJ963.GBP"],"gpt_icon":0},{"id":"2492316531","title":"Looking For Yields: AES, Agree Realty And Hormel Foods Are Consistent Moneymakers","url":"https://stock-news.laohu8.com/highlight/detail?id=2492316531","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492316531?lang=en_us&edition=fundamental","pubTime":"2024-12-19 01:00","pubTimestamp":1734541217,"startTime":"0","endTime":"0","summary":"Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. AES, Agree Realty and Hormel Foods have rewarded shareholders for decades and recently announced dividend increases. These companies currently offer dividend yields of around 3-5%.The AES Corporation  is a diversified power generation and utility company operating in 15 countries.The company has increased its dividends every year for the last 10 years. According to its most recent dividend hike announcement on Dec. 6, its board of directors raised the quarterly dividend by 2% to $0.17595 per share, which is equal to $0.7038 annually. Currently, the dividend yield on the stock stands at 5.19%.Unlock the hidden potential of commercial real estate — This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xhn8Q0W7_Rqll8.Ie1laeQ--~B/aD00ODA7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/baccbc621afeb8e0f0e5dede92d66380","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xhn8Q0W7_Rqll8.Ie1laeQ--~B/aD00ODA7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/baccbc621afeb8e0f0e5dede92d66380"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/looking-yields-aes-agree-realty-170017411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["US6M.BOND","US10Y.BOND","BK4504","US3Y.BOND","BK4585","LU1093756168.USD","US5Y.BOND","BK4519","IE00B7SZLL34.SGD","BK4105","US30Y.BOND","HRL","BK4588","IE00B19Z3B42.SGD","BK4231","LU0061475181.USD","BK4533","LU1093756325.SGD","BK4212","BK4080","US12M.BOND","ADC","IE0002270589.USD","AES","IE00B19Z3581.USD","US7Y.BOND","US2Y.BOND"],"gpt_icon":0},{"id":"2492186384","title":"Rezolve AI Investors Agree to $49 Million Equity Conversion; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2492186384","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492186384?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:54","pubTimestamp":1734530099,"startTime":"0","endTime":"0","summary":"Rezolve AI  shares were rallying premarket Wednesday after the company said its leading investors have agreed to convert $49 million of an outstanding convertible loan note into equity.The conversion is expected to position the company to expand its artificial intelligence-driven offerings, Rezolve AI said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b8f0f643dd68f9fe9d1e50e8822a9319","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","ISBC","BK4211","BK4023","EQR","BK4080","BK4215","RZLV","ADC","BK4231","BK4585"],"gpt_icon":0},{"id":"2492186353","title":"Press Release: Akari Therapeutics Announces Key Leadership Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2492186353","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492186353?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:51","pubTimestamp":1734529860,"startTime":"0","endTime":"0","summary":"Samir R. Patel, M.D., appointed as Chief Executive Officer. Dr. Patel currently serves as founder and principal of PranaBio Investments, LLC, a firm providing consulting, strategic advisory, and investment services for small cap biotechnology companies. He is also a consultant to GE Global Research, GE's innovation engine that is creating novel products and solutions across several sectors including biomanufacturing and biotechnology.He has more than 20 years of experience in life sciences including founding SPEC Pharma, LLC, a company that develops and manufactures injectables used in human and veterinary applications. Previously, Dr. Patel held multiple roles in Medical Affairs with Centocor, Inc. . He holds multiple patents, has been an author on several publications and has been an investigator in numerous clinical research studies. He has served on the boards of several public companies, including Rezolute Bio.Mr. Gaslightwala is a well-established biotechnology / pharmaceutical i","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1929549753.HKD","LU1267930813.SGD","BK4568","LU0882574055.USD","LU1244550577.SGD","LU0345769128.USD","LU0203347892.USD","BK4231","LU1023059063.AUD","LU1057294990.SGD","LU1066051225.USD","BK4007","LU1032955483.USD","LU0203345920.USD","LU0792757196.USD","IE00B3PB1722.GBP","LENZ","LU1674673428.USD","LU2089984988.USD","LU1162221912.USD","LU1244550494.USD","LU1585245621.USD","IE0009355771.USD","R","IE000M9KFDE8.USD","IE0002141913.USD","BK4504","LU0122379950.USD","IE00B7SZLL34.SGD","LU1032466523.USD","LU1506573853.SGD","BK4080","LU0640476718.USD","IE00BGHQF631.EUR","AKTX","LU2133065610.SGD","JNJ","LU1674673691.USD","LU0466842654.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","LU0795875086.SGD","BCG","IE00B2B36J28.USD","LU0114720955.EUR","ADC","BK4532","BK4232","LU1894683264.USD"],"gpt_icon":0},{"id":"2492291778","title":"Creditors Agree to Restructuring for Argentina’s Clisa","url":"https://stock-news.laohu8.com/highlight/detail?id=2492291778","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492291778?lang=en_us&edition=fundamental","pubTime":"2024-12-18 07:09","pubTimestamp":1734476957,"startTime":"0","endTime":"0","summary":"Cia Latinoamericana de Infraestructura y Servicios Corp., the holding company behind Buenos Aires’ subway operators, won extensive support from international bondholders to restructure debt, according to people familiar with the matter.","market":"fut","thumbnail":"https://www.bnnbloomberg.ca/resizer/v2/A62W6FCCPZPWX6Q4YXU33QSLQQ.jpg?smart=true&auth=93e1f5e873f9a292fd81c9fe839163e2f8cf02a55d816661c89fc90f998f5575&width=500&height=333","type":0,"news_type":0,"thumbnails":["https://www.bnnbloomberg.ca/resizer/v2/A62W6FCCPZPWX6Q4YXU33QSLQQ.jpg?smart=true&auth=93e1f5e873f9a292fd81c9fe839163e2f8cf02a55d816661c89fc90f998f5575&width=500&height=333"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.bnnbloomberg.ca/investing/2024/12/17/creditors-agree-to-restructuring-for-argentinas-clisa/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bnn_bloomberg_highlight","symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2492877918","title":"Top Analysts Agree VeChain (VET) Price Rally Is Ready to Continue: Here’s the Next Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2492877918","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492877918?lang=en_us&edition=fundamental","pubTime":"2024-12-18 04:34","pubTimestamp":1734467663,"startTime":"0","endTime":"0","summary":"Leading crypto analyst World of Charts has identified a technical setup for VeChain, spotting a bullish pennant formation that suggests upside potential.The analyst notes that VET has successfully broken out of this continuation pattern, typically seen after strong rallies, and projects a potential 50% move higher from current levels to around $0.09.The technical structure shows a sharp upward movement followed by a period of consolidation, forming the characteristic pennant shape. This breakout above the pattern’s upper resistance carries added significance due to the accompanying volume surge, lending credibility to the move’s sustainability.Read Also: Monero  Price Breaks Key Resistance: What Next?Adding weight to the technical outlook, veteran crypto strategist Michal van de Poppe emphasizes VeChain’s robust fundamental backdrop. He highlights the thriving ecosystem development, particularly noting the rapid expansion of VeBetter as a cornerstone project.The post Top Analysts Agree","market":"us","thumbnail":"https://academy-public.coinmarketcap.com/srd-optimized-uploads/b07fe4a6637c4668977955608efe54cc.png","type":0,"news_type":0,"thumbnails":["https://academy-public.coinmarketcap.com/srd-optimized-uploads/b07fe4a6637c4668977955608efe54cc.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/6761e050d657ec7f716b21cc/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4080","ADC","VET","BK4231","BK4563","BK4585","BK4588","BK4213"],"gpt_icon":0},{"id":"2492957482","title":"U.S. FDA Grants Breakthrough Therapy Designation to Trodelvy® (sacituzumab govitecan-hziy) for Second-Line Treatment of Extensive-Stage Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2492957482","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492957482?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:30","pubTimestamp":1734442200,"startTime":"0","endTime":"0","summary":"FOSTER CITY, Calif., December 17, 2024----Gilead Sciences, Inc.  today announced that the U.S. Food and Drug Administration  has granted Breakthrough Therapy Designation to Trodelvy  for the treatment of adult patients with extensive-stage small cell lung cancer  whose disease has progressed on or after platinum-based chemotherapy.The Breakthrough Therapy Designation is based on results from the global Phase 2 TROPiCS-03 study ES-SCLC cohort, which showed encouraging results with Trodelvy as a second-line treatment for ES-SCLC. As recently presented at the IASLC 2024 World Conference on Lung Cancer, Trodelvy demonstrated promising antitumor activity in both platinum-resistant  and platinum-sensitive  disease, and the safety profile was consistent with previous Trodelvy studies. These data support further investigation of Trodelvy in ES-SCLC and Gilead plans to initiate a Phase 3 clinical trial in this patient population.Trodelvy  is a first-in-class Trop-2-directed antibody-drug conjug","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Tl.oL3DFSs5rYUJtfVIWDA--~B/aD01NzY7dz0xNzI4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7ed339f6d17d2ea412d8cd876b41e37b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Tl.oL3DFSs5rYUJtfVIWDA--~B/aD01NzY7dz0xNzI4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7ed339f6d17d2ea412d8cd876b41e37b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/u-fda-grants-breakthrough-therapy-133000372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002270589.USD","LU0289739699.SGD","IE00B3T34201.USD","LU1571399168.USD","IE00B19Z3B42.SGD","SAR","IE00BZ1G4Q59.USD","LU0234570918.USD","BK4231","LU1066053197.SGD","LU1585245621.USD","BK4532","IE00BSNM7G36.USD","BK4566","HR","LU0320765992.SGD","BK4213","LU2087621335.USD","LU0889565916.HKD","BK4583","SSI","ADC","GILD","BK4203","LU0109394709.USD","IE00B19Z3581.USD","LU1839511570.USD","BK4550","PR","LU1066051498.USD","BK4588","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","BK4080","CINV","LU0058720904.USD","BK4135","BK4585","LU2468319806.SGD","BK4139","LU1430594728.SGD","BK4578","BK4568","BK4225"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agreerealty.com","stockEarnings":[{"period":"1week","weight":-0.0601},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.0575},{"period":"6month","weight":0.141},{"period":"1year","weight":0.1242},{"period":"ytd","weight":0.1147}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agree Realty Corporation (the Company), a Maryland corporation, is a fully integrated real estate investment trust (REIT) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (GLA) of approximately 44.9 million square feet.","yearOnYearQuotes":[{"month":1,"riseRate":0.566667,"avgChangeRate":-0.004913},{"month":2,"riseRate":0.433333,"avgChangeRate":-0.00204},{"month":3,"riseRate":0.566667,"avgChangeRate":0.014268},{"month":4,"riseRate":0.566667,"avgChangeRate":0.002707},{"month":5,"riseRate":0.516129,"avgChangeRate":0.017098},{"month":6,"riseRate":0.677419,"avgChangeRate":0.011409},{"month":7,"riseRate":0.677419,"avgChangeRate":0.024183},{"month":8,"riseRate":0.451613,"avgChangeRate":0.001804},{"month":9,"riseRate":0.483871,"avgChangeRate":-0.005771},{"month":10,"riseRate":0.548387,"avgChangeRate":-0.001244},{"month":11,"riseRate":0.645161,"avgChangeRate":0.002723},{"month":12,"riseRate":0.483871,"avgChangeRate":0.011511}],"exchange":"NYSE","name":"Agree","nameEN":"Agree"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agree,ADC,Agree股票,Agree股票老虎,Agree股票老虎国际,Agree行情,Agree股票行情,Agree股价,Agree股市,Agree股票价格,Agree股票交易,Agree股票购买,Agree股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction